Clinical trial
Predicting Psychotic Relapse Using Speech-Based Early Detection
NCT06978894 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Psychotic Relapse Using Speech-Based Early Detection
- Lead sponsor
- Douglas Mental Health University Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 27, 2024
- Completion date
- July 1, 2029
- Enrollment
- 250 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
psychosis